New Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. USO
2. DHR
3. NVDA
4. SPY
5. AMD
6. GM
7. SMCI
8. NOW
9. EFX
10. IBM

Go back to New Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan
(NYSE: RCUS) Delayed: 29.97 +0.49 (1.66%)
Previous Close $29.48    52 Week High $ 
Open $29.21    52 Week Low $ 
Day High $30.02    P/E N/A 
Day Low $28.68    EPS $ 
Volume 1,035,309